BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200116T103000
DTEND;TZID=America/New_York:20200116T163000
DTSTAMP:20260405T170408
CREATED:20191206T175155Z
LAST-MODIFIED:20191206T175155Z
UID:3653-1579170600-1579192200@carb-x.org
SUMMARY:Exploring Opportunities to Reform Antimicrobial Payment and Post-Market Incentives
DESCRIPTION:Speakers include Kevin Outterson\, Executive Director of CARB-X. \nThe rise of antimicrobial resistance and the corresponding lack of novel antibiotic development impacts the ability of physicians to provide appropriate care for patients. The greatest barriers to a robust antibiotic ecosystem are low return on investment (ROI) and limited market opportunities\, in part due to payment decisions that don’t reflect the value of antibiotics that extends beyond the hospital stay. For years\, policy makers and other stakeholders have been exploring ways to improve the antibiotic ecosystem through development\, regulatory\, and market incentives proposals\, though to date there has been limited impact on manufacturers’ ability to generate adequate ROI. \nThis public meeting will highlight recent actions implemented by stakeholders in the U.S. and globally\, and present additional opportunities to effect change to payment and the costs and returns to antimicrobial investment systems through legislative\, administrative\, and private sector mechanisms.
URL:https://carb-x.org/event/exploring-opportunities-to-reform-antimicrobial-payment-and-post-market-incentives/
LOCATION:Washington Marriott at Metro Center\, 775 12th Street NW\, Washington\, DC\, 20005\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200121T080000
DTEND;TZID=America/New_York:20200121T170000
DTSTAMP:20260405T170408
CREATED:20200127T163257Z
LAST-MODIFIED:20200127T163257Z
UID:3757-1579593600-1579626000@carb-x.org
SUMMARY:Davos 2020 World Economic Forum - Novo Nordisk Foundation and Novo Holdings: The Broken Model of Antimicrobial resistance
DESCRIPTION:Moderator: Kevin Outterson\, Executive Director\, CARB-X\, Professor of Law\, Boston University \nPanel: \n\nLars Rebien Sorensen\, Chairman of the Novo Nordisk Foundation and Novo Holdings\nJeremy Farrar\, Director\, Wellcome Trust\nDr. Malin Grape\, Head of Antibiotics Unit\, The Public Health Agency of Sweden\nThomas Cueni\, Director General\, IFPMA\nJayasree K. Iyer\, Executive Director\, Access to Medicine Foundation\nFrancesca Colombo\, Head of the Health Division\, OECD\n\nAntimicrobial resistance is one of the biggest threats to human health. The Novo Nordisk Foundation is hosting a session at the World Economic Forum’s Annual Meeting in Davos urging governments\, the biopharma industry and other stakeholders to step up the urgency and respond to the crisis in #antimicrobialresistance with new funding models.  \nTo watch a recording of this panel\, please click here. 
URL:https://carb-x.org/event/davos-2020-world-economic-forum-novo-nordisk-foundation-and-novo-holdings-the-broken-model-of-antimicrobial-resistance/
LOCATION:DAVOS-KLOSTERS\, Switzerland
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200121T110000
DTEND;TZID=America/New_York:20200121T123000
DTSTAMP:20260405T170408
CREATED:20200127T162345Z
LAST-MODIFIED:20200127T162345Z
UID:3755-1579604400-1579609800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Testing for the potential of emergence of antimicrobial resistance
DESCRIPTION:In this webinar\, the following aspects will be presented: \n\nWhat are the most common techniques used to measure the extent of the risk of selecting for resistance when using a novel direct-acting antibacterial. What are the advantages and limitations of these techniques?\nWhat are some techniques that may be used to understand the origins of resistance selection?\nHow to rationalize/manage the risk of translation of the resistance selection from in vitro to the clinical settings?\n\nThe presentation will be followed by a Q&A session. \nThis presentation was also part of the ‘Bootcamp: Understanding the Potential for Antimicrobial Resistance in the Drug Discovery Process’\, jointly organized by GARDP\, CARB-X\, REPAIR Impact Fund\, JPIMAR and Wellcome Trust at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance 2019.  \n  \nSpeaker: Michael Mourez\, Head BacteriOmics Platform\, Evotec (France) \nModerator: Laura Piddock\, Director Scientific Affairs\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-testing-for-the-potential-of-emergence-of-antimicrobial-resistance/
END:VEVENT
END:VCALENDAR